{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:36:38Z","timestamp":1792798598190,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fundamental Research Grant Scheme","award":["FRGS\/1\/2024\/STG02\/IMU\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2024\/STG02\/IMU\/02\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11753-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:02:47Z","timestamp":1775044967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative roles between Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) in lung and colorectal cancer: insights into tumorigenesis and metastasis"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0815-1943","authenticated-orcid":false,"given":"Amar Harris","family":"Arifin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5401-2620","authenticated-orcid":false,"given":"Ahmad Firdaus Ahmad","family":"Sukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-158X","authenticated-orcid":false,"given":"Baskaran","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4190-8288","authenticated-orcid":false,"given":"Koh Rhun","family":"Yian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-087X","authenticated-orcid":false,"given":"Shamala","family":"Salvamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"2","key":"11753_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jncc.2024.05.001","volume":"4","author":"W Cao","year":"2024","unstructured":"Cao W, Qin K, Li F, Chen W (2024) Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). J Natl Cancer Cent 4(2):128\u2013134. https:\/\/doi.org\/10.1016\/j.jncc.2024.05.001","journal-title":"J Natl Cancer Cent"},{"key":"11753_CR2","doi-asserted-by":"publisher","unstructured":"Tariq M, Ahmed M, Khan M, Khan F (2024) A cell-free DNA colorectal cancer screening test promising enhanced accessibility and early detection. Int J Colorectal Dis 39(1). https:\/\/doi.org\/10.1007\/s00384-024-04706-8","DOI":"10.1007\/s00384-024-04706-8"},{"key":"11753_CR3","doi-asserted-by":"publisher","unstructured":"Martinez ME, Schmeler KM, Lajous M, Newman LA (2024) Cancer screening in low- and middle-income countries. Am Soc Clin Oncol Educ Book 44(3). https:\/\/doi.org\/10.1200\/edbk_431272","DOI":"10.1200\/edbk_431272"},{"issue":"6","key":"11753_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/nu16060800","volume":"16","author":"P Marino","year":"2024","unstructured":"Marino P, Mininni M, Deiana G, Marino G, Divella R, Bochicchio I et al (2024) Healthy lifestyle and cancer risk: Modifiable risk factors to prevent cancer. Nutrients 16(6):800. https:\/\/doi.org\/10.3390\/nu16060800","journal-title":"Nutrients"},{"key":"11753_CR5","doi-asserted-by":"publisher","unstructured":"Li Z, Zhang YY, Zhang H, Yang J, Chen Y, Lu H (2022) Asymmetric cell division and tumor heterogeneity. Front Cell Dev Biol 10. https:\/\/doi.org\/10.3389\/fcell.2022.938685","DOI":"10.3389\/fcell.2022.938685"},{"key":"11753_CR6","doi-asserted-by":"publisher","unstructured":"Liu S, Yu J, Zhang H, Liu J (2022) TP53 Co-Mutations in advanced EGFR-mutated non\u2013small cell lung cancer: Prognosis and therapeutic strategy for cancer therapy. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.860563","DOI":"10.3389\/fonc.2022.860563"},{"key":"11753_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cancergen.2022.10.002","volume":"268\u2013269","author":"X Peng","year":"2022","unstructured":"Peng X, Zhang T, Jia X, Wang T, Lin H, Li G et al (2022) Impact of a haplotype (composed of the APC, KRAS, and TP53 genes) on colorectal adenocarcinoma differentiation and patient prognosis. Cancer Genet 268\u2013269:115\u2013123. https:\/\/doi.org\/10.1016\/j.cancergen.2022.10.002","journal-title":"Cancer Genet"},{"issue":"11","key":"11753_CR8","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.3390\/cancers13112641","volume":"13","author":"A Maiti","year":"2021","unstructured":"Maiti A, Okano I, Oshi M, Okano M, Tian W, Kawaguchi T et al (2021) Altered expression of secreted mediator genes that mediate aggressive breast cancer metastasis to distant organs. Cancers 13(11):2641. https:\/\/doi.org\/10.3390\/cancers13112641","journal-title":"Cancers"},{"key":"11753_CR9","doi-asserted-by":"publisher","unstructured":"Ortiz MA, Mikhailova T, Li X, Porter BA, Bah A, Kotula L (2021) Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition. Cell Commun Signal 19(1). https:\/\/doi.org\/10.1186\/s12964-021-00750-x","DOI":"10.1186\/s12964-021-00750-x"},{"issue":"1","key":"11753_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X (2022) The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol OncolJ Hematol Oncol 15(1):129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"11753_CR11","doi-asserted-by":"publisher","first-page":"119152","DOI":"10.1016\/j.lfs.2021.119152","volume":"271","author":"S Khan","year":"2021","unstructured":"Khan S, Masood M, Gaur H, Ahmad S, Syed MA (2021) Long non-coding RNA: An immune cells perspective. Life Sci 271:119152. https:\/\/doi.org\/10.1016\/j.lfs.2021.119152","journal-title":"Life Sci"},{"issue":"4","key":"11753_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/biology14040442","volume":"14","author":"H Tani","year":"2025","unstructured":"Tani H (2025) Biomolecules interacting with long noncoding RNAs. Biology 14(4):442. https:\/\/doi.org\/10.3390\/biology14040442","journal-title":"Biology"},{"key":"11753_CR13","doi-asserted-by":"publisher","first-page":"155329","DOI":"10.1016\/j.prp.2024.155329","volume":"258","author":"I Kazmi","year":"2024","unstructured":"Kazmi I, Afzal M, Almalki WH, RJyothi S, Alzarea SI, Kumar A et al (2024) From oncogenes to tumor suppressors: The dual role of ncRNAs in fibrosarcoma. Pathol - Res Pract 258:155329. https:\/\/doi.org\/10.1016\/j.prp.2024.155329","journal-title":"Pathol - Res Pract"},{"issue":"4","key":"11753_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.59249\/tdbj7410","volume":"96","author":"PR Chowdhury","year":"2023","unstructured":"Chowdhury PR, Salvamani S, Gunasekaran B, Peng HB, Ulaganathan V (2023) H19: An oncogenic long non-coding RNA in colorectalcancer. Yale J Biol Med 96(4):495\u2013509. https:\/\/doi.org\/10.59249\/tdbj7410","journal-title":"Yale J Biol Med"},{"issue":"4","key":"11753_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.59249\/vhye2306","volume":"96","author":"YZ Hor","year":"2023","unstructured":"Hor YZ, Salvamani S, Gunasekaran B, Yian KR (2023) CRNDE: A Pivotal Oncogenic Long Non-Coding RNA inCancers. Yale J Biol Med 96(4):511\u2013526. https:\/\/doi.org\/10.59249\/vhye2306","journal-title":"Yale J Biol Med"},{"key":"11753_CR16","doi-asserted-by":"publisher","unstructured":"Liau XL, Salvamani S, Gunasekaran B, Chellappan DK, Rhodes A, Ulaganathan V et al (2023) CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer. Br J Biomed Sci 80. https:\/\/doi.org\/10.3389\/bjbs.2023.11103","DOI":"10.3389\/bjbs.2023.11103"},{"issue":"1","key":"11753_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10142-025-01610-4","volume":"25","author":"SK Sritharan","year":"2025","unstructured":"Sritharan SK, Arifin AH, Salvamani S, Koh RY, Gunasekaran B (2025) LSINCT5: a pivotal oncogenic long non-coding RNA in cancers. Funct Integr Genomics 25(1):115. https:\/\/doi.org\/10.1007\/s10142-025-01610-4PubMed PMID: 40455308","journal-title":"Funct Integr Genomics"},{"key":"11753_CR18","doi-asserted-by":"publisher","unstructured":"Ong J, Sritharan S, Arifin AHB, Gunasekaran B, Koh RY, Bakar NA et al (2025) GAS5 in colorectal cancer: A multifaceted long non-coding RNA in tumor suppression, Prognosis and therapeutic targeting. Adv Pharm Bull 1. https:\/\/doi.org\/10.34172\/apb.025.45936","DOI":"10.34172\/apb.025.45936"},{"issue":"5","key":"11753_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1261\/rna.079388.122","volume":"29","author":"A Monroy-Eklund","year":"2023","unstructured":"Monroy-Eklund A, Taylor C, Weidmann CA, Burch C, Laederach A (2023) Structural analysis of MALAT1 long noncoding RNA in cells and in evolution. RNA 29(5):691\u2013704. https:\/\/doi.org\/10.1261\/rna.079388.122","journal-title":"RNA"},{"issue":"12","key":"11753_CR20","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.26355\/eurrev_201806_15249","volume":"22","author":"C Guo","year":"2018","unstructured":"Guo C, Wang X, Chen LP, Li M, Li M, Hu YH et al (2018) Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt\/\u03b2-catenin signaling pathway. Eur Rev Med Pharmacol Sci 22(12):3703\u20133712. https:\/\/doi.org\/10.26355\/eurrev_201806_15249","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"11753_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40364-023-00467-8","volume":"11","author":"J Hou","year":"2023","unstructured":"Hou J, Zhang G, Wang X, Wang Y, Wang K (2023) Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance. Biomark Res 11(1):23. https:\/\/doi.org\/10.1186\/s40364-023-00467-8","journal-title":"Biomark Res"},{"issue":"51","key":"11753_CR22","doi-asserted-by":"publisher","first-page":"eabq7289","DOI":"10.1126\/sciadv.abq7289","volume":"8","author":"H Miao","year":"2022","unstructured":"Miao H, Wu F, Li Y, Qin C, Zhao Y, Xie M et al (2022) MALAT1 modulates alternative splicing by cooperating with the splicing factors PTBP1 and PSF. Sci Adv 8(51):eabq7289. https:\/\/doi.org\/10.1126\/sciadv.abq7289","journal-title":"Sci Adv"},{"issue":"34","key":"11753_CR23","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.2174\/1381612821666150724115625","volume":"21","author":"Y Wu","year":"2015","unstructured":"Wu Y, Huang C, Meng X, Li J, Long Noncoding (2015) RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease. Curr Pharm Des 21(34):5017\u20135028. https:\/\/doi.org\/10.2174\/1381612821666150724115625","journal-title":"Curr Pharm Des"},{"key":"11753_CR24","doi-asserted-by":"publisher","first-page":"154991","DOI":"10.1016\/j.prp.2023.154991","volume":"253","author":"AA Bhat","year":"2024","unstructured":"Bhat AA, Afzal O, Afzal M, Gupta G, Thapa R, Ali H et al (2024) MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting. Pathol - Res Pract 253:154991. https:\/\/doi.org\/10.1016\/j.prp.2023.154991","journal-title":"Pathol - Res Pract"},{"key":"11753_CR25","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.2147\/IJGM.S393270","volume":"15","author":"W Shen","year":"2022","unstructured":"Shen W, Yu Q, Pu Y, Xing C (2022) Upregulation of long noncoding RNA MALAT1 in Colorectal cancer promotes radioresistance and aggressive malignance. Int J Gen Med 15:8365\u20138380. https:\/\/doi.org\/10.2147\/IJGM.S393270","journal-title":"Int J Gen Med"},{"issue":"1","key":"11753_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","volume":"10","author":"C Xue","year":"2025","unstructured":"Xue C, Chu Q, Shi Q, Zeng Y, Lu J, Li L (2025) Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. Signal Transduct Target Ther 10(1):106. https:\/\/doi.org\/10.1038\/s41392-025-02142-w","journal-title":"Signal Transduct Target Ther"},{"key":"11753_CR27","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.2147\/CMAR.S169406","volume":"10","author":"ZX Li","year":"2018","unstructured":"Li ZX, Zhu QN, Zhang HB, Hu Y, Wang G, Zhu YS (2018) MALAT1: a potential biomarker in cancer. Cancer Manag Res 10:6757. 10.2147\/CMAR.S169406 PubMed PMID: 30584369","journal-title":"Cancer Manag Res"},{"key":"11753_CR28","doi-asserted-by":"publisher","unstructured":"Dongxin T, Zhu Y, Fengxi L, Li L, Bing Y, Ruyi Z et al (2019) Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer. Cell Signal 57. https:\/\/doi.org\/10.1016\/j.cellsig.2019.01.013PubMed PMID: 30716387","DOI":"10.1016\/j.cellsig.2019.01.013"},{"issue":"1","key":"11753_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbadis.2014.11.013","volume":"1852","author":"MH Yang","year":"2014","unstructured":"Yang MH, Hu ZY, Xu C, Xie LY, Wang XY, Chen SY et al (2014) MALAT1 promotes colorectal cancer cell proliferation\/migration\/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta 1852(1):166. https:\/\/doi.org\/10.1016\/j.bbadis.2014.11.013PubMed PMID: 25446987","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"11753_CR30","doi-asserted-by":"publisher","first-page":"e70091","DOI":"10.1002\/cnr2.70091","volume":"7","author":"A Tasnim","year":"2024","unstructured":"Tasnim A, Sumaiya AA, Noman AA, Tahsin A, Saba AA, Ahmed R et al (2024) A comparative meta-analysis on the association of lncRNAs MALAT1, HOTAIR, and AFAP1 \u2010 AS1 with the risk of developing lymph node metastasis in lung cancer. Cancer Rep 7(12):e70091. https:\/\/doi.org\/10.1002\/cnr2.70091","journal-title":"Cancer Rep"},{"key":"11753_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12885-017-3151-6","volume":"17","author":"JZ Wang","year":"2017","unstructured":"Wang JZ, Xiang JJ, Wu LG, Bai YS, Chen ZW, Yin XQ et al (2017) A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis. BMC Cancer 17:167. https:\/\/doi.org\/10.1186\/s12885-017-3151-6PubMed PMID: 28253859","journal-title":"BMC Cancer"},{"issue":"1","key":"11753_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12672-024-01133-7","volume":"15","author":"J Luo","year":"2024","unstructured":"Luo J, Ren Q, Liu X, Zheng Q, Yang L, Meng M et al (2024) LncRNA MALAT-1 modulates EGFR-TKI resistance in lung adenocarcinoma cells by downregulating miR-125. Discov Oncol 15(1):379. https:\/\/doi.org\/10.1007\/s12672-024-01133-7","journal-title":"Discov Oncol"},{"issue":"6","key":"11753_CR33","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.18632\/aging.205675","volume":"16","author":"SH Lin","year":"2024","unstructured":"Lin SH, Lu JW, Hsieh WT, Chou YE, Su TC, Tsai TJ et al (2024) Evaluation of the clinical significance of long non-coding RNA MALAT1 genetic variants in human lung adenocarcinoma. Aging 16(6):5740. https:\/\/doi.org\/10.18632\/aging.205675PubMed PMID: 38517388","journal-title":"Aging"},{"issue":"1","key":"11753_CR34","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1186\/s12885-023-11347-7","volume":"23","author":"J Roh","year":"2023","unstructured":"Roh J, Kim B, Im M, Jang W, Chae Y, Kang J et al (2023) MALAT1-regulated gene expression profiling in lung cancer cell lines. BMC Cancer 23(1):818. https:\/\/doi.org\/10.1186\/s12885-023-11347-7","journal-title":"BMC Cancer"},{"issue":"2","key":"11753_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/1759-7714.13265","volume":"11","author":"J Pan","year":"2020","unstructured":"Pan J, Bian Y, Cao Z, Lei L, Pan J, Huang J et al (2020) Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta\u2010analysis. Thorac Cancer 11(2):329\u2013335. https:\/\/doi.org\/10.1111\/1759-7714.13265","journal-title":"Thorac Cancer"},{"key":"11753_CR36","doi-asserted-by":"publisher","unstructured":"Wang M, Fu Y, Zhong C, Gacche RN, Wu P (2023) Long non-coding RNA and Evolving drug resistance in lung cancer. Heliyon 9(12). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22591","DOI":"10.1016\/j.heliyon.2023.e22591"},{"key":"11753_CR37","doi-asserted-by":"publisher","unstructured":"Zhou Q, Liu L, Zhou J, Chen Y, Xie D, Yao Y et al (2021) Novel insights into MALAT1 function as a MicroRNA sponge in NSCLC. Front Oncol 11. https:\/\/doi.org\/10.3389\/fonc.2021.758653","DOI":"10.3389\/fonc.2021.758653"},{"key":"11753_CR38","doi-asserted-by":"publisher","first-page":"154991","DOI":"10.1016\/j.prp.2023.154991","volume":"253","author":"AA Bhat","year":"2024","unstructured":"Bhat AA, Afzal O, Afzal M, Gupta G, Thapa R, Ali H et al (2024) MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting. Pathol - Res Pract 253:154991. https:\/\/doi.org\/10.1016\/j.prp.2023.154991","journal-title":"Pathol - Res Pract"},{"issue":"12","key":"11753_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.arbres.2019.03.026","volume":"55","author":"C Feng","year":"2019","unstructured":"Feng C, Zhao Y, Li Y, Zhang T, Ma Y, Liu Y (2019) LncRNA MALAT1 promotes lung cancer proliferation and gefitinib resistance by acting as a miR-200a Sponge. Arch Bronconeumol 55(12):627\u2013633. https:\/\/doi.org\/10.1016\/j.arbres.2019.03.026","journal-title":"Arch Bronconeumol"},{"issue":"23","key":"11753_CR40","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1182\/blood.v126.23.1641.1641","volume":"126","author":"ME Balasis","year":"2015","unstructured":"Balasis ME, Merelvede J, Kunigal S, Ren X, Ma Y, Zhang Q et al (2015) Molecular characterization of SRSF2 mutation identifies a clinically relevant lncrna (MALAT1) in chronic myelomonocytic leukemia (CMML). Blood 126(23):1641\u20131641. https:\/\/doi.org\/10.1182\/blood.v126.23.1641.1641","journal-title":"Blood"},{"issue":"11","key":"11753_CR41","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.3390\/ijms23115870","volume":"23","author":"EA Ahmed","year":"2022","unstructured":"Ahmed EA, Rajendran P, Scherthan H (2022) The microRNA-202 as a diagnostic biomarker and a potential tumor suppressor. Int J Mol Sci 23(11):5870. https:\/\/doi.org\/10.3390\/ijms23115870 PubMed PMID: 35682549; PubMed Central PMCID: PMC9180238","journal-title":"Int J Mol Sci"},{"issue":"19","key":"11753_CR42","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.3390\/cancers15194723","volume":"15","author":"J Fu","year":"2023","unstructured":"Fu J, Imani S, Wu MY, Wu RC (2023) MicroRNA-34 family in cancers: Role, mechanism, and therapeutic potential. Cancers 15(19):4723 doi:10.3390\/cancers15194723 PubMed PMID: 37835417; PubMed Central PMCID: PMC10571940","journal-title":"Cancers"},{"key":"11753_CR43","doi-asserted-by":"publisher","unstructured":"Zhou Q, Liu L, Zhou J, Chen Y, Xie D, Yao Y et al (2021) Novel insights into MALAT1 function as a MicroRNA sponge in NSCLC. Front Oncol 11. https:\/\/doi.org\/10.3389\/fonc.2021.758653","DOI":"10.3389\/fonc.2021.758653"},{"key":"11753_CR44","doi-asserted-by":"publisher","unstructured":"Roh J, Kim B, Im M, Jang W, Chae Y, Kang J et al (2023) MALAT1-regulated gene expression profiling in lung cancer cell lines. BMC Cancer 23(1). https:\/\/doi.org\/10.1186\/s12885-023-11347-7","DOI":"10.1186\/s12885-023-11347-7"},{"key":"11753_CR45","doi-asserted-by":"publisher","unstructured":"Zhang J, Wang M, Wang J, Wang W (2022) JMJD2C-mediated long non-coding RNA MALAT1\/microRNA-503-5p\/SEPT2 axis worsens non-small cell lung cancer. Cell Death Dis 13(1). https:\/\/doi.org\/10.1038\/s41419-022-04513-5","DOI":"10.1038\/s41419-022-04513-5"},{"issue":"1","key":"11753_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11060-014-1613-0","volume":"121","author":"L Shen","year":"2015","unstructured":"Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z (2015) Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neurooncol 121(1):101\u2013108. https:\/\/doi.org\/10.1007\/s11060-014-1613-0","journal-title":"J Neurooncol"},{"issue":"1","key":"11753_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/cancers16010234","volume":"16","author":"MA Hussein","year":"2024","unstructured":"Hussein MA, Valinezhad K, Adel E, Munirathinam G (2024) MALAT-1 is a key regulator of epithelial\u2013mesenchymal transition in cancer: A potential therapeutic target for metastasis. Cancers 16(1):234. https:\/\/doi.org\/10.3390\/cancers16010234","journal-title":"Cancers"},{"key":"11753_CR48","doi-asserted-by":"publisher","unstructured":"Anushka D, Robert W (2019) New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20(2). https:\/\/doi.org\/10.1038\/s41580-018-0080-4PubMed PMID: 30459476","DOI":"10.1038\/s41580-018-0080-4"},{"key":"11753_CR49","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.12659\/msm.913308","volume":"25","author":"C Liu","year":"2019","unstructured":"Liu C, Li H, Jia J, Ruan X, Liu Y, Zhang X (2019) High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) expression promotes proliferation, migration, and invasion of non-small cell lung cancer via ERK\/Mitogen-Activated Protein Kinase (MAPK) signaling pathway. Med Sci Monit 25:5143\u20135149. https:\/\/doi.org\/10.12659\/msm.913308","journal-title":"Med Sci Monit"},{"issue":"1","key":"11753_CR50","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1186\/s12885-023-11347-7","volume":"23","author":"J Roh","year":"2023","unstructured":"Roh J, Kim B, Im M, Jang W, Chae Y, Kang J et al (2023) MALAT1-regulated gene expression profiling in lung cancer cell lines. BMC Cancer 23(1):818. https:\/\/doi.org\/10.1186\/s12885-023-11347-7","journal-title":"BMC Cancer"},{"issue":"1","key":"11753_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1021\/acsami.8b18288","volume":"11","author":"N Gong","year":"2019","unstructured":"Gong N, Teng X, Li J, Liang XJ (2019) Antisense oligonucleotide-conjugated nanostructure-targeting lncRNA MALAT1 inhibits cancer metastasis. ACS Appl Mater Interfaces 11(1):37\u201342. https:\/\/doi.org\/10.1021\/acsami.8b18288","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"11753_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-024-02112-8","volume":"10","author":"M Liu","year":"2025","unstructured":"Liu M, Wang Y, Zhang Y, Hu D, Tang L, Zhou B et al (2025) Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. Signal Transduct Target Ther 10(1):73. https:\/\/doi.org\/10.1038\/s41392-024-02112-8","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"11753_CR53","doi-asserted-by":"publisher","first-page":"e0308009","DOI":"10.1371\/journal.pone.0308009","volume":"19","author":"M Masrour","year":"2024","unstructured":"Masrour M, Khanmohammadi S, Habibzadeh A, Fallahtafti P (2024) LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and meta-analysis. PLoS ONE 19(10):e0308009. https:\/\/doi.org\/10.1371\/journal.pone.0308009PubMed PMID: 39471147","journal-title":"PLoS ONE"},{"issue":"4","key":"11753_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ame2.12093","volume":"2","author":"Y Lyu","year":"2019","unstructured":"Lyu Y, Bai L, Qin C (2019) Long noncoding RNAs in neurodevelopment and Parkinson\u2019s disease. Anim Models Exp Med 2(4):239\u2013251. https:\/\/doi.org\/10.1002\/ame2.12093","journal-title":"Anim Models Exp Med"},{"key":"11753_CR55","doi-asserted-by":"publisher","unstructured":"Zhang C, Yao K, Zhang J, Wang C, Wang C, Qin C (2020) Long noncoding RNA MALAT1 promotes colorectal cancer progression by acting as a ceRNA of miR-508\u20105p to regulate RAB14 expression. Huang G, editor. BioMed Res Int. 2020(1). https:\/\/doi.org\/10.1155\/2020\/4157606","DOI":"10.1155\/2020\/4157606"},{"issue":"4","key":"11753_CR56","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/genes15040474","volume":"15","author":"DJ Kadhim","year":"2024","unstructured":"Kadhim DJ, Azari H, Sokhangouy SK, Hassanian SM, Alshekarchi HI, Goshayeshi L et al (2024) G-Protein signaling modulator 2 as a potential biomarker in colorectal cancer: Integrative analysis using genetic profiling and pan-cancer studies. Genes 15(4):474. https:\/\/doi.org\/10.3390\/genes15040474","journal-title":"Genes"},{"issue":"6","key":"11753_CR57","first-page":"3174","volume":"7","author":"HT Zheng","year":"2014","unstructured":"Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P et al (2014) High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 7(6):3174\u20133181 PubMed PMID: 25031737; PubMed Central PMCID: PMC4097248","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"11753_CR58","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12935-022-02540","volume":"22","author":"WW Xu","year":"2022","unstructured":"Xu WW, Jin J, Wu XY, Ren QL, Farzaneh M (2022) MALAT1-related signaling pathways in colorectal cancer. Cancer Cell Int 22(1):126. https:\/\/doi.org\/10.1186\/s12935-022-02540y PubMed PMID: 35305641; PubMed Central PMCID: PMC8933897","journal-title":"Cancer Cell Int"},{"issue":"2","key":"11753_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ncrna6020022","volume":"6","author":"G Arun","year":"2020","unstructured":"Arun G, Aggarwal D, Spector DL (2020) MALAT1 long non-coding RNA: Functional implications. Non-Coding RNA 6(2):22 doi:10.3390\/ncrna6020022 PubMed PMID: 32503170; PubMed Central PMCID: PMC7344863","journal-title":"Non-Coding RNA"},{"issue":"5","key":"11753_CR60","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.21037\/tcr.2019.08.23","volume":"8","author":"H Wang","year":"2019","unstructured":"Wang H, Huang C, Yao X (2019) The functions of long non-coding RNAs in colorectal cancer. Transl Cancer Res 8(5):2192\u20132204. https:\/\/doi.org\/10.21037\/tcr.2019.08.23","journal-title":"Transl Cancer Res"},{"issue":"11","key":"11753_CR61","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.3390\/ijms22116147","volume":"22","author":"AF Radwan","year":"2021","unstructured":"Radwan AF, Shaker OG, El-Boghdady NA, Senousy MA (2021) Association of MALAT1 and PVT1 variants, expression profiles and target miRNA-101 and miRNA-186 with colorectal cancer: Correlation with epithelial-mesenchymal transition. Int J Mol Sci 22(11):6147. https:\/\/doi.org\/10.3390\/ijms22116147","journal-title":"Int J Mol Sci"},{"key":"11753_CR62","doi-asserted-by":"publisher","unstructured":"Li H, Zhang Y, Liu Y, Qu Z, Liu Y, Qi J (2022) Long noncoding RNA MALAT1 and colorectal cancer: A propensity score analysis of two prospective cohorts. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.824767","DOI":"10.3389\/fonc.2022.824767"},{"key":"11753_CR63","doi-asserted-by":"publisher","unstructured":"Tian W, Du Y, Ma Y, Gu L, Zhou J, Deng D (2018) MALAT1\u2013miR663a negative feedback loop in colon cancer cell functions through direct miRNA\u2013lncRNA binding. Cell Death Dis 9(9). https:\/\/doi.org\/10.1038\/s41419-018-0925-y","DOI":"10.1038\/s41419-018-0925-y"},{"key":"11753_CR64","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ebiom.2018.12.049","volume":"41","author":"M Zhuang","year":"2019","unstructured":"Zhuang M, Zhao S, Jiang Z, Wang S, Sun P, Quan J et al (2019) MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. EBioMedicine 41:286\u2013298. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.049","journal-title":"EBioMedicine"},{"issue":"10","key":"11753_CR65","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"CY Loh","year":"2019","unstructured":"Loh CY, Chai J, Tang T, Wong W, Sethi G, Shanmugam M et al (2019) The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells 8(10):1118. https:\/\/doi.org\/10.3390\/cells8101118","journal-title":"Cells"},{"issue":"9","key":"11753_CR66","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/kjm2.12698","volume":"39","author":"F Yang","year":"2023","unstructured":"Yang F, Gong S, Qiu D (2023) Circ- MALAT1 accelerates cell proliferation and epithelial mesenchymal transformation of colorectal cancer through regulating miR \u2010506\u20103p\/ KAT6B axis. Kaohsiung J Med Sci 39(9):862\u2013872. https:\/\/doi.org\/10.1002\/kjm2.12698","journal-title":"Kaohsiung J Med Sci"},{"key":"11753_CR67","doi-asserted-by":"publisher","unstructured":"Huang H, Shi Z, Li Y, Zhu G, Chen C, Zhang Z et al (2022) Pyroptosis-related LncRNA signatures correlate with lung adenocarcinoma prognosis. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.850943","DOI":"10.3389\/fonc.2022.850943"},{"issue":"3","key":"11753_CR68","doi-asserted-by":"publisher","first-page":"357","DOI":"10.17305\/bjbms.2019.4408","volume":"20","author":"J Zhang","year":"2020","unstructured":"Zhang J, Li Q, Xue B, He R (2020) MALAT1 inhibits the Wnt\/\u03b2-catenin signaling pathway in colon cancer cells and affects cell proliferation and apoptosis. Bosn J Basic Med Sci 20(3):357. https:\/\/doi.org\/10.17305\/bjbms.2019.4408PubMed PMID: 31733641","journal-title":"Bosn J Basic Med Sci"},{"key":"11753_CR69","doi-asserted-by":"publisher","unstructured":"Min-Hui Y, Zhi-Yan H, Chuan X, Lin-Ying X, Xiao-Yan W, Shi-You C et al (2015) MALAT1 promotes colorectal cancer cell proliferation\/migration\/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta 1852(1). https:\/\/doi.org\/10.1016\/j.bbadis.2014.11.013PubMed PMID: 25446987","DOI":"10.1016\/j.bbadis.2014.11.013"},{"issue":"1","key":"11753_CR70","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-020-01562-6","volume":"39","author":"J Xu","year":"2020","unstructured":"Xu J, Xiao Y, Liu B, Pan S, Liu Q, Shan Y et al (2020) Exosomal MALAT1 sponges miR-26a\/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K\/Akt pathway. J Exp Clin Cancer Res 39(1):54. https:\/\/doi.org\/10.1186\/s13046-020-01562-6","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"11753_CR71","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s11658-019-0175-8","volume":"24","author":"Y Si","year":"2019","unstructured":"Si Y, Yang Z, Ge Q, Yu L, Yao M, Sun X et al (2019) Long non-coding RNA Malat1 activated autophagy, hence promoting cell proliferation and inhibiting apoptosis by sponging miR-101 in colorectal cancer. Cell Mol Biol Lett 24(1):50. https:\/\/doi.org\/10.1186\/s11658-019-0175-8","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"11753_CR72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41419-023-05667-6","volume":"14","author":"Y Duan","year":"2023","unstructured":"Duan Y, Yue K, Ye B, Chen P, Zhang J, He Q et al (2023) LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2. Cell Death Dis 14(2):149. https:\/\/doi.org\/10.1038\/s41419-023-05667-6PubMed PMID: 36813772; PubMed Central PMCID: PMC9946937","journal-title":"Cell Death Dis"},{"key":"11753_CR73","doi-asserted-by":"publisher","unstructured":"Chen D, Xu T, Hoyon Chang H, Song Q, Zhu Y, Han Y et al (2019) The role of MALAT1 in cancer. J Cancer Sci Clin Ther 03(01). https:\/\/doi.org\/10.26502\/jcsct.5079016","DOI":"10.26502\/jcsct.5079016"},{"issue":"2","key":"11753_CR74","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ncrna.2024.01.015","volume":"9","author":"D Xu","year":"2024","unstructured":"Xu D, Wang W, Wang D, Ding J, Zhou Y, Zhang W (2024) Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance. Non-Coding RNA Res 9(2):388\u2013406. https:\/\/doi.org\/10.1016\/j.ncrna.2024.01.015PubMed PMID: 38511067; PubMed Central PMCID: PMC10950606","journal-title":"Non-Coding RNA Res"},{"key":"11753_CR75","doi-asserted-by":"publisher","first-page":"146791","DOI":"10.1016\/j.gene.2022.146791","volume":"843","author":"K Cervena","year":"2022","unstructured":"Cervena K, Vodenkova S, Vymetalkova V (2022) MALAT1 in colorectal cancer: Its implication as a diagnostic, prognostic, and predictive biomarker. Gene 843:146791. https:\/\/doi.org\/10.1016\/j.gene.2022.146791","journal-title":"Gene"},{"key":"11753_CR76","doi-asserted-by":"publisher","unstructured":"Kim S (2018) Computational model for predicting the relationship between Micro-RNAs and their target messenger RNAs in breast and colon cancers. Cancer Inf 17. https:\/\/doi.org\/10.1177\/1176935118785145","DOI":"10.1177\/1176935118785145"},{"key":"11753_CR77","doi-asserted-by":"publisher","unstructured":"Li J, Dhilipkannah P, Holden VK, Sachdeva A, Todd NW, Jiang F (2024) Dysregulation of lncRNA MALAT1 contributes to lung cancer in African Americans by modulating the tumor immune microenvironment [Internet]. Oncology; [cited 2025 Jul 27]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.04.04.24305363 doi:10.1101\/2024.04.04.24305363","DOI":"10.1101\/2024.04.04.24305363"},{"key":"11753_CR78","doi-asserted-by":"publisher","first-page":"205873841985969","DOI":"10.1177\/2058738419859699","volume":"33","author":"S Wei","year":"2019","unstructured":"Wei S, Wang K, Huang X, Zhao Z, Zhao Z (2019) LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p\/programmed death-ligand 1 axis. Int J Immunopathol Pharmacol 33:2058738419859699 doi:10.1177\/2058738419859699 PubMed PMID: 31240979","journal-title":"Int J Immunopathol Pharmacol"},{"key":"11753_CR79","doi-asserted-by":"publisher","unstructured":"Nan Cchuan, Zhang N, Cheung KCP, Zhang H dong, Li W, Hong C, ying et al (2020) Knockdown of lncRNA MALAT1 alleviates LPS-induced acute lung injury via inhibiting apoptosis through the miR-194-5p\/FOXP2 axis. Front Cell Dev Biol. ;8. https:\/\/doi.org\/10.3389\/fcell.2020.586869","DOI":"10.3389\/fcell.2020.586869"},{"key":"11753_CR80","doi-asserted-by":"publisher","unstructured":"Yang J, Jiang G, Huang L, Liu Z, Jiang R, Cao G et al (2023) The Long non-coding RNA MALAT1 functions as a competing endogenous RNA to regulate vascular remodeling by sponging miR-145-5p\/HK2 in hypertension. Clin Exp Hypertens 45(1). https:\/\/doi.org\/10.1080\/10641963.2023.2284658","DOI":"10.1080\/10641963.2023.2284658"},{"key":"11753_CR81","doi-asserted-by":"publisher","unstructured":"Li ZX, Zhu QN, Zhang HB, Hu Y, Wang G, Zhu YS MALAT1: a potential biomarker in cancer. Cancer Manag Res 2018;Volume 10:6757\u20136768. https:\/\/doi.org\/10.2147\/CMAR.S169406","DOI":"10.2147\/CMAR.S169406"},{"key":"11753_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncrna.2024.08.002","volume":"10","author":"M Hashemi","year":"2025","unstructured":"Hashemi M, Mohandesi Khosroshahi E, Asadi S, Tanha M, Ghatei Mohseni F, Abdolmohammad Sagha R et al (2025) Emerging roles of non-coding RNAs in modulating the PI3K\/Akt pathway in cancer. Non-Coding RNA Res 10:1\u201315. https:\/\/doi.org\/10.1016\/j.ncrna.2024.08.002","journal-title":"Non-Coding RNA Res"},{"key":"11753_CR83","doi-asserted-by":"publisher","first-page":"109676","DOI":"10.1016\/j.cellsig.2020.109676","volume":"73","author":"X Zheng","year":"2020","unstructured":"Zheng X, Ren J, Peng B, Ye J, Wu X, Zhao W et al (2020) MALAT1 overexpression promotes the growth of colon cancer by repressing \u03b2-catenin degradation. Cell Signal 73:109676. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109676","journal-title":"Cell Signal"},{"key":"11753_CR84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cellsig.2019.01.013","volume":"57","author":"D Tang","year":"2019","unstructured":"Tang D, Yang Z, Long F, Luo L, Yang B, Zhu R et al (2019) Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer. Cell Signal 57:21\u201328. https:\/\/doi.org\/10.1016\/j.cellsig.2019.01.013","journal-title":"Cell Signal"},{"issue":"4","key":"11753_CR85","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/bjc.2014.383","volume":"111","author":"Q Ji","year":"2014","unstructured":"Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z et al (2014) Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ\/PTBP2 complex. Br J Cancer 111(4):736\u2013748. https:\/\/doi.org\/10.1038\/bjc.2014.383","journal-title":"Br J Cancer"},{"issue":"4","key":"11753_CR86","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1158\/1535-7163.MCT-16-0591","volume":"16","author":"P Li","year":"2017","unstructured":"Li P, Zhang X, Wang H, Wang L, Liu T, Du L et al (2017) MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2. Mol Cancer Ther 16(4):739\u2013751. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0591","journal-title":"Mol Cancer Ther"},{"key":"11753_CR87","doi-asserted-by":"publisher","unstructured":"Xu WW, Jin J, Wu Xyu, Ren QL, Farzaneh M (2022) MALAT1-related signaling pathways in colorectal cancer. Cancer Cell Int 22(1). https:\/\/doi.org\/10.1186\/s12935-022-02540-y","DOI":"10.1186\/s12935-022-02540-y"},{"key":"11753_CR88","doi-asserted-by":"publisher","unstructured":"Hou J, Zhang G, Wang X, Wang Y, Wang K (2023) Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance. Biomark Res 11(1). https:\/\/doi.org\/10.1186\/s40364-023-00467-8","DOI":"10.1186\/s40364-023-00467-8"},{"issue":"3","key":"11753_CR89","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.can-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Ei\u00dfmann M, Hsu J, Kim Y, Hung G et al (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73(3):1180\u20131189. https:\/\/doi.org\/10.1158\/0008-5472.can-12-2850","journal-title":"Cancer Res"},{"issue":"10","key":"11753_CR90","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/CM9.0000000000003090","volume":"137","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qin Y, Wu Y, Xu H, Shu Y (2024) Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications. Chin Med J (Engl) 137(10):1151\u20131159. https:\/\/doi.org\/10.1097\/CM9.0000000000003090","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"11753_CR91","doi-asserted-by":"publisher","first-page":"12517","DOI":"10.18632\/oncotarget.13573","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zhao L, Lei L, Bond Lau W, Lau B, Yang Q et al (2017) LncRNAs: the bridge linking RNA and colorectal cancer. Oncotarget 8(7):12517\u201312532. https:\/\/doi.org\/10.18632\/oncotarget.13573","journal-title":"Oncotarget"},{"issue":"18","key":"11753_CR92","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3390\/cells11182811","volume":"11","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhang Y, Ding Y, Huang J, Yao J, Xie Z et al (2022) Regulating the expression of HIF-1\u03b1 or lncRNA: Potential directions for cancer therapy. Cells 11(18):2811. https:\/\/doi.org\/10.3390\/cells11182811","journal-title":"Cells"},{"issue":"17","key":"11753_CR93","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3390\/cancers16172940","volume":"16","author":"E \u00c7akan","year":"2024","unstructured":"\u00c7akan E, Lara OD, Szymanowska A, Bayraktar E, Chavez-Reyes A, Lopez-Berestein G et al (2024) Therapeutic antisense oligonucleotides in oncology: From bench to bedside. Cancers 16(17):2940. https:\/\/doi.org\/10.3390\/cancers16172940","journal-title":"Cancers"},{"key":"11753_CR94","doi-asserted-by":"publisher","first-page":"114657","DOI":"10.1016\/j.bcp.2021.114657","volume":"190","author":"YA Uthman","year":"2021","unstructured":"Uthman YA, Ibrahim KG, Abubakar B, Bello MB, Malami I, Imam MU et al (2021) MALAT1: A promising therapeutic target for the treatment of metastatic colorectal cancer. Biochem Pharmacol 190:114657. https:\/\/doi.org\/10.1016\/j.bcp.2021.114657","journal-title":"Biochem Pharmacol"},{"key":"11753_CR95","doi-asserted-by":"publisher","unstructured":"Qiao FH, Tu M, Liu HY (2021) Role of MALAT1 in gynecological cancers: Pathologic and therapeutic aspects (Review). Oncol Lett 21(4). https:\/\/doi.org\/10.3892\/ol.2021.12594","DOI":"10.3892\/ol.2021.12594"},{"key":"11753_CR96","doi-asserted-by":"publisher","unstructured":"Long JP, Shen Y (2023) Detection method has independent prognostic significance in the PLCO lung screening trial. Sci Rep 13(1). https:\/\/doi.org\/10.1038\/s41598-023-40415-y","DOI":"10.1038\/s41598-023-40415-y"},{"key":"11753_CR97","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.biopha.2016.05.017","volume":"82","author":"S Chen","year":"2016","unstructured":"Chen S, Wu H, Lv N, Wang H, Wang Y, Tang Q et al (2016) LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer. Biomed Pharmacother 82:583\u2013588. https:\/\/doi.org\/10.1016\/j.biopha.2016.05.017","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"11753_CR98","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3892\/ol.2016.4138","volume":"11","author":"D Ren","year":"2016","unstructured":"Ren D, Li H, Li R, Sun J, Guo P, Han H et al (2016) Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications. Oncol Lett 11(3):1621\u20131630. https:\/\/doi.org\/10.3892\/ol.2016.4138","journal-title":"Oncol Lett"},{"issue":"42","key":"11753_CR99","doi-asserted-by":"publisher","first-page":"e31333","DOI":"10.1097\/md.0000000000031333","volume":"101","author":"X Wang","year":"2022","unstructured":"Wang X, Qi R, Xu Y, Lu X, Shi Q, Wang Y et al (2022) Clinicopathological characteristics and prognosis of colon cancer with lung metastasis without liver metastasis: A large population-based analysis. Med (Baltim) 101(42):e31333. https:\/\/doi.org\/10.1097\/md.0000000000031333","journal-title":"Med (Baltim)"},{"key":"11753_CR100","doi-asserted-by":"publisher","unstructured":"Li F, Tian C, Wang Y, Wu H, Jin M, Du X et al (2024) Prognostic significance of peripheral and tumor-infiltrating lymphocytes in newly diagnosed stage III\/IV non-small-cell lung cancer. Front Med 11. https:\/\/doi.org\/10.3389\/fmed.2024.1349178","DOI":"10.3389\/fmed.2024.1349178"},{"issue":"6","key":"11753_CR101","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.3390\/curroncol28060447","volume":"28","author":"K Chen","year":"2021","unstructured":"Chen K, Collins G, Wang H, Toh JWT (2021) Pathological features and prognostication in colorectal cancer. Curr Oncol 28(6):5356\u20135383. https:\/\/doi.org\/10.3390\/curroncol28060447","journal-title":"Curr Oncol"},{"issue":"2","key":"11753_CR102","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.21873\/invivo.12377","volume":"35","author":"T Hayama","year":"2021","unstructured":"Hayama T, Ozawa T, Asako K, Kondo R, Ono K, Okada Y et al (2021) Impact of colon cancer location on the prognostic significance of nutritional indexes and inflammatory markers. Vivo 35(2):1261\u20131269. https:\/\/doi.org\/10.21873\/invivo.12377","journal-title":"Vivo"},{"key":"11753_CR103","doi-asserted-by":"publisher","unstructured":"Peng H, Liu G, Bao Y, Zhang X, Zhou L, Huang C et al (2021) Prognostic factors of colorectal cancer: A comparative study on patients with or without liver metastasis. Front Oncol 11. https:\/\/doi.org\/10.3389\/fonc.2021.626190","DOI":"10.3389\/fonc.2021.626190"},{"issue":"9","key":"11753_CR104","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.21037\/jtd.2018.08.51","volume":"10","author":"D Li","year":"2018","unstructured":"Li D, Yuan X, Liu J, Li C, Li W (2018) Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis. J Thorac Dis 10(9):5298\u20135307. https:\/\/doi.org\/10.21037\/jtd.2018.08.51","journal-title":"J Thorac Dis"},{"key":"11753_CR105","doi-asserted-by":"publisher","unstructured":"Yan Y, Song D, Wu J, Wang J (2020) Long non-coding RNAs link oxidized low-density lipoprotein with the inflammatory response of macrophages in atherogenesis. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.00024","DOI":"10.3389\/fimmu.2020.00024"},{"issue":"7","key":"11753_CR106","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.18632\/oncotarget.23483","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, Wang L, Zhang G, Lu C, Chu H, Yang R et al (2018) MALAT1\/miR-101-3p\/MCL1 axis mediates cisplatin resistance in lung cancer. Oncotarget 9(7):7501\u20137512. https:\/\/doi.org\/10.18632\/oncotarget.23483","journal-title":"Oncotarget"},{"key":"11753_CR107","doi-asserted-by":"publisher","unstructured":"Zhou S, Peng J, Xiao L, Zhou C, Fang Y, Ou Q et al (2021) TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability. Cell Death Dis 12(5). https:\/\/doi.org\/10.1038\/s41419-021-03734-4","DOI":"10.1038\/s41419-021-03734-4"},{"issue":"10","key":"11753_CR108","doi-asserted-by":"publisher","first-page":"11733","DOI":"10.18632\/oncotarget.7367","volume":"7","author":"ZY Hu","year":"2016","unstructured":"Hu ZY, Wang XY, bin Guo W, Xie LY, qi Huang Y, Liu YP et al (2016) Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells. Oncotarget 7(10):11733\u201311743. https:\/\/doi.org\/10.18632\/oncotarget.7367","journal-title":"Oncotarget"},{"key":"11753_CR109","doi-asserted-by":"crossref","unstructured":"Chang L, Haifeng L, Jia J, Xinjian R, Yangfang L, Xia Z (2019) High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) expression promotes proliferation, migration, and invasion of non-small cell lung cancer via ERK\/Mitogen-Activated Protein Kinase (MAPK) signaling pathway. Med Sci Monit Int Med J Exp Clin Res 25. 1012659\/MSM.913308 PubMed PMID: 31293277","DOI":"10.12659\/MSM.913308"},{"issue":"22","key":"11753_CR110","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.3390\/cells12222594","volume":"12","author":"C Yang","year":"2023","unstructured":"Yang C, Hardy P (2023) The Multifunctional nature of the MicroRNA\/AKT3 Regulatory axis in human cancers. Cells 12(22):2594. https:\/\/doi.org\/10.3390\/cells12222594","journal-title":"Cells"},{"key":"11753_CR111","doi-asserted-by":"publisher","unstructured":"Jungwook R, Boseong K, Mijung I, Wongyi J, Yeonsoo C, JiHoon K et al (2023) MALAT1-regulated gene expression profiling in lung cancer cell lines. BMC Cancer 23(1). https:\/\/doi.org\/10.1186\/s12885-023-11347-7PubMed PMID: 37667226","DOI":"10.1186\/s12885-023-11347-7"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11753-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:02:51Z","timestamp":1775044971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11753-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11753"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11753-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"573"}}